Island Pharmaceuticals Limited (ASX:ILA)
Australia flag Australia · Delayed Price · Currency is AUD
0.425
+0.005 (1.19%)
At close: Mar 9, 2026

Island Pharmaceuticals Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2018
Net Income
-7.2-3.92-2.86-2.83-2.61-2.13
Upgrade
Stock-Based Compensation
0.750.75-0.30.451.16
Upgrade
Other Operating Activities
2.350.030.090.09-0.13-0.03
Upgrade
Change in Accounts Receivable
0.710.71-0.8700.04-0.06
Upgrade
Change in Accounts Payable
-0.26-0.260.47-0.330.310.23
Upgrade
Change in Other Net Operating Assets
-0.08-0.080.020.070.06-0.11
Upgrade
Operating Cash Flow
-3.67-2.77-3.16-2.7-1.88-0.94
Upgrade
Cash Acquisitions
-----0.08
Upgrade
Investing Cash Flow
-0.84----0.08
Upgrade
Short-Term Debt Issued
--0.39--0.02
Upgrade
Total Debt Issued
--0.39--0.02
Upgrade
Short-Term Debt Repaid
--0.45----
Upgrade
Total Debt Repaid
--0.45----
Upgrade
Net Debt Issued (Repaid)
--0.450.39--0.02
Upgrade
Issuance of Common Stock
7.659.052.73--7.5
Upgrade
Other Financing Activities
-0.25-0.24-0.33-0.18--0.22
Upgrade
Financing Cash Flow
7.418.362.79-0.18-7.3
Upgrade
Foreign Exchange Rate Adjustments
-0.0100.040.090.20.02
Upgrade
Miscellaneous Cash Flow Adjustments
------0
Upgrade
Net Cash Flow
2.885.59-0.34-2.79-1.676.46
Upgrade
Cash Interest Paid
--0.010.01--
Upgrade
Cash Income Tax Paid
--0.87-0.39---
Upgrade
Levered Free Cash Flow
-2.35-1.78-2.31-1.78-0.9-0.12
Upgrade
Unlevered Free Cash Flow
-2.35-1.76-2.28-1.78-0.9-0.12
Upgrade
Change in Working Capital
0.370.37-0.39-0.260.410.06
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.